8-K: Chemed Reports Mixed Q4 2024 Results; VITAS Growth Offset by Roto-Rooter Decline

Chemed Corporation announces its fourth-quarter 2024 financial results, highlighting revenue growth in its VITAS Healthcare segment but a decline in its Roto-Rooter segment.

Summary

• Chemed Corporation reported a 9.2% increase in revenue to $640.0 million for the fourth quarter of 2024.
• GAAP Diluted Earnings per Share (EPS) increased by 2.0% to $6.02, while Adjusted Diluted EPS rose by 3.5% to $6.83.
• VITAS Healthcare saw a 17.4% increase in net patient revenue, reaching $411.0 million, with a 14.6% increase in Average Daily Census (ADC) to 22,179.
• Roto-Rooter experienced a 2.9% decrease in revenue to $229.0 million.
• The company repurchased 388,235 shares of Chemed stock for $212.8 million during the quarter.
• Chemed provides 2025 guidance, estimating VITAS revenue growth of 10.5% to 11.3% and Roto-Rooter revenue growth of 2.4% to 3.0%.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While VITAS shows strong growth, the decline in Roto-Rooter's performance and margin pressures temper the overall outlook. The guidance for 2025 is cautiously optimistic.

Positives

• VITAS Healthcare experienced significant growth in revenue and ADC.
• Chemed maintains a strong cash position with $178.4 million in cash and cash equivalents and no debt.
• The company continues to repurchase shares, indicating confidence in its future prospects.
• VITAS completed the acquisition of Covenant Health's hospice assets, contributing $11 million to $12 million in revenue.
• VITAS admitted its first patient in Pasco County, Florida, and was awarded a certificate of need in Marion County, Florida.

Negatives

• Roto-Rooter's revenue and Adjusted EBITDA declined.
• VITAS's Adjusted EBITDA margin declined by 112-basis points.
• Roto-Rooter's Adjusted EBITDA margin declined by 120-basis points.
• Hurricanes Helene and Milton negatively impacted VITAS admissions by an estimated 150-175 patients.

Risks

• Changes in regulations governing the hospice care or plumbing and drain cleaning industries could impact Chemed's operations.
• Periodic changes in reimbursement levels and procedures under Medicare and Medicaid programs pose a risk.
• Difficulties in predicting patient length of stay and estimating potential Medicare reimbursement obligations could affect financial results.
• The current shortage of qualified nurses, other healthcare professionals, and licensed plumbing and drain cleaning technicians presents a challenge.
• Chemed's dependence on patient referral sources could impact VITAS's performance.

Future Outlook

Chemed expects VITAS revenue to increase by 10.5% to 11.3% in 2025, with ADC increasing by 8.5% to 9.0%. Roto-Rooter is forecasted to achieve full-year 2025 revenue growth of 2.4% to 3.0%. Full-year 2025 earnings per diluted share are estimated to be in the range of $24.95 to $25.45.

Management Comments

• Roto-Rooter's revenue and associated income is expected to accelerate during the year, as Roto-Rooter management's business improvement initiatives continue to build momentum.
• VITAS revenue growth and EBITDA margin, prior to Medicare Cap in the second and third quarters, will be adversely impacted by the initiatives required to moderate the impact of the Medicare Cap rate differential.

Industry Context

Chemed operates in the healthcare and home services industries. The hospice care market is driven by an aging population and increasing awareness of end-of-life care options. The plumbing and drain cleaning market is influenced by factors such as housing construction, infrastructure development, and consumer spending on home maintenance.

Comparison to Industry Standards

• While specific competitor data isn't provided, Chemed's VITAS segment's growth can be compared to other publicly traded hospice providers like Amedisys or LHC Group to assess its relative performance.
• Roto-Rooter's performance can be benchmarked against other home service companies like ServiceMaster or Frontdoor to evaluate its competitive position in the plumbing and drain cleaning market.

Stakeholder Impact

• Shareholders may react positively to VITAS's growth but negatively to Roto-Rooter's decline.
• Employees at VITAS may benefit from the company's expansion, while those at Roto-Rooter may face challenges due to the segment's underperformance.
• Customers of VITAS will continue to receive end-of-life care services.
• Customers of Roto-Rooter will continue to receive plumbing and drain cleaning services.

Next Steps

• Chemed will host a conference call on February 27, 2025, to discuss the results and provide an update on its business.
• The company will continue to execute its growth strategy, focusing on expanding VITAS's hospice services and improving Roto-Rooter's performance through business improvement initiatives.

Key Dates